Engler H, Taurog A, Luthy C, Dorris M L
Endocrinology. 1983 Jan;112(1):86-95. doi: 10.1210/endo-112-1-86.
The mechanism of reversible and irreversible inhibition of thyroid peroxidase (TPO)-catalyzed iodination by thioureylene drugs was investigated using a model incubation system. The major observations may be summarized as follows. 1) TPO is inactivated by 1-methyl-2-mercaptoimidazole and propylthiouracil even in the presence of a relatively high concentration of iodide. The extent of this inactivation depends on the ratio of iodide to drug. 2) Spectral changes observed on oxidation of the drugs with the peroxidase-iodide system were very similar to those observed when the drugs were oxidized nonenzymatically with I3-. These findings support the view that oxidized iodine is an intermediate in TPO-catalyzed oxidation of the drugs. 3) Under conditions where TPO is largely inactivated, inhibition of iodination is complete and irreversible. Drug metabolism, on the other hand, occurs to a limited extent. 4) Under conditions where TPO is only partially inactivated, inhibition of iodination is transient (reversible). In this case, drug metabolism is extensive, and higher oxidation products (sulfate and sulfinic acid) are observed. Inhibition of iodination occurs only during the interval required to reduce the drug concentration to a low level. Thereafter, iodination may occur at a rate close to that observed in the absence of drug. Based on these and other observations, a scheme is presented to explain the mechanism of reversible and irreversible inhibition of iodination. In essence, the type of inhibition depends on the relative rates and extent of TPO inactivation and drug oxidation. These rates, in turn, depend primarily on the iodide to drug concentration ratio. A high ratio favors extensive drug oxidation and reversible inhibition. A low ratio favors TPO inactivation and irreversible inhibition.
利用模型孵育系统研究了硫脲类药物对甲状腺过氧化物酶(TPO)催化碘化反应的可逆性和不可逆性抑制机制。主要观察结果总结如下:1)即使在存在相对高浓度碘化物的情况下,1-甲基-2-巯基咪唑和丙硫氧嘧啶也会使TPO失活。这种失活的程度取决于碘化物与药物的比例。2)在过氧化物酶-碘化物系统中药物氧化时观察到的光谱变化与用I3-非酶氧化药物时观察到的光谱变化非常相似。这些发现支持了氧化碘是TPO催化药物氧化的中间体这一观点。3)在TPO大量失活的条件下,碘化反应的抑制是完全且不可逆的。另一方面,药物代谢仅在有限程度上发生。4)在TPO仅部分失活的条件下,碘化反应的抑制是短暂的(可逆的)。在这种情况下,药物代谢广泛,并且观察到更高的氧化产物(硫酸盐和亚磺酸)。碘化反应的抑制仅在将药物浓度降低到低水平所需的时间间隔内发生。此后,碘化反应可能以接近在无药物情况下观察到的速率发生。基于这些及其他观察结果,提出了一个方案来解释碘化反应的可逆性和不可逆性抑制机制。本质上,抑制类型取决于TPO失活和药物氧化的相对速率和程度。反过来,这些速率主要取决于碘化物与药物的浓度比。高比例有利于广泛的药物氧化和可逆性抑制。低比例有利于TPO失活和不可逆性抑制。